Efficacy of novel plasmid DNA encoding vaccinia antigens in improving current smallpox vaccination strategy
- 22 May 2006
- Vol. 24 (21) , 4461-4470
- https://doi.org/10.1016/j.vaccine.2005.08.010
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation programVaccine, 2005
- Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challengeVaccine, 2004
- Developing New Smallpox VaccinesEmerging Infectious Diseases, 2001
- Enhancement of Cellular Immune Response in HIV-1 Seropositive Individuals: A DNA-Based TrialClinical Immunology, 1999
- Use of DNAs Expressing HIV-1 Env and Noninfectious HIV-1 Particles to Raise Antibody Responses in MiceVirology, 1995
- Molecular characterization of a prominent antigen of the vaccinia virus envelopeVirology, 1988
- Complications of Smallpox Vaccination, 1968: Results of Ten Statewide SurveysThe Journal of Infectious Diseases, 1970
- Deaths attributable to smallpox vaccination, 1959 to 1966, and 1968Published by American Medical Association (AMA) ,1970
- Eczema VaccinatumBMJ, 1964
- Acute Pericarditis after Smallpox VaccinationNew England Journal of Medicine, 1958